| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2007/06/09 | 01 : 51 | PR Newswire (US) | Boston Life Sciences, Inc. Changes Name to Alseres Pharmaceuticals, Inc. | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/06/06 | 04 : 58 | PR Newswire (US) | Boston Life Sciences, Inc. Announces Webcast of 2007 Annual Meeting | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/05/30 | 01 : 00 | PR Newswire (US) | Boston Life Sciences Names Scientific and Clinical Advisors for Nerve Repair Program | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/05/09 | 23 : 00 | PR Newswire (US) | Boston Life Sciences to Host 2007 1st Quarter Conference Call | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/05/03 | 23 : 30 | PR Newswire (US) | Boston Life Sciences Raises $6 Million Through Issuance of a Convertible Promissory Note to a New Fund | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/05/02 | 00 : 44 | PR Newswire (US) | Boston Life Sciences, Inc. to Present at the 2007 Biotechnology Industry Organization's (BIO) Annual BIO International Conventio | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/04/17 | 23 : 00 | PR Newswire (US) | Boston Life Sciences Reports New Option Grants Under NASDAQ Market Rule 4350 | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/04/17 | 01 : 57 | PR Newswire (US) | Boston Life Sciences, Inc. Announces Presentation of Cethrin(R) Phase I/IIa 6-Month Results at 75th Annual Meeting of the Americ | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/04/16 | 23 : 00 | PR Newswire (US) | Boston Life Sciences Appoints Frank Bobe as Executive Vice President and Chief Business Officer | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/04/13 | 05 : 22 | PR Newswire (US) | Boston Life Sciences, Inc. Announces Data to be Presented on Cethrin(R) for Spinal Cord Injury at the 2007 American Association | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/04/03 | 06 : 07 | PR Newswire (US) | Boston Life Sciences, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/03/30 | 00 : 45 | PR Newswire (US) | Boston Life Sciences To Host 2006 4th Quarter Conference Call | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/03/28 | 00 : 33 | PR Newswire (US) | Boston Life Sciences Completes Final License Fee Payment for Exclusive, Worldwide Rights to Develop and Commercialize Phase II S | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/03/27 | 04 : 55 | PR Newswire (US) | Boston Life Sciences Enters Into $15 Million Convertible Promissory Note Purchase Agreement and Amends Existing Promissory Notes | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/03/23 | 00 : 25 | PR Newswire (US) | Dr. Robert Langer Named as Chairman of Boston Life Sciences, Inc. Newly Formed Science and Technology Committee of the Board of | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/03/08 | 01 : 00 | PR Newswire (US) | Boston Life Sciences, Inc. To Present at the Sachs Associates 6th Annual North America Forum for Investing & Partnering in Biote | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/02/14 | 04 : 55 | PR Newswire (US) | Boston Life Sciences Issues Amended Promissory Notes for Up to an Additional $2 Million | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/02/08 | 00 : 28 | PR Newswire (US) | Boston Life Sciences, Inc. to Participate in the 2007 BIO CEO & Investor Conference | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/02/07 | 04 : 43 | PR Newswire (US) | Boston Life Sciences Announces the Appointment of Henry Brem, M.D. and Gary Frashier to the Board of Directors | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/02/02 | 01 : 07 | PR Newswire (US) | Boston Life Sciences Sponsors Movement Disorder Society's 1st Annual Neuroimaging in Parkinson's Disease Symposium | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2007/01/04 | 23 : 26 | PR Newswire (US) | Boston Life Sciences Acquires Rights to Develop and Commercialize Promising Phase II Spinal Cord Injury Drug, Cethrin(R), in Exc | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2006/12/14 | 03 : 32 | PR Newswire (US) | Boston Life Sciences, Inc. Announces Webcast of 2006 Annual Meeting | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2006/11/06 | 23 : 17 | PR Newswire (US) | Boston Life Sciences, Inc. to Present at the CIBC World Markets 17th Annual Healthcare Conference | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2006/11/03 | 02 : 39 | PR Newswire (US) | Boston Life Sciences Issues Promissory Notes for Up to $8 Million | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2006/11/01 | 01 : 12 | PR Newswire (US) | Boston Life Sciences, Inc. to Present at the 8th Annual Rodman & Renshaw Annual Healthcare Conference | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2006/10/31 | 06 : 21 | PR Newswire (US) | Boston Life Sciences, Inc. to Present at the 8th Annual Mass Biotech Council's Mass Opportunities Conference | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2006/09/26 | 01 : 33 | PR Newswire (US) | Boston Life Sciences, Inc. Announces Findings from Review of POET-1 Study of ALTROPANE(R) Molecular Imaging Agent | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2006/08/31 | 00 : 10 | PR Newswire (US) | Peter Savas, Chairman and CEO of Boston Life Sciences, Inc., Scheduled to Appear on New England Cable News 'New England Busines | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2006/08/11 | 05 : 46 | PR Newswire (US) | Boston Life Sciences, Inc. Announces the Issuance of a U.S. Patent Licensed to BLSI by Harvard et al that Covers Methods for th | NASDAQ:BLSI | Boston Life Sciences (MM) |
| 2006/07/27 | 23 : 31 | PR Newswire (US) | Boston Life Sciences, Inc. Elects William L.S. Guinness to Its Board of Directors | NASDAQ:BLSI | Boston Life Sciences (MM) |